Free 7-day Trial
All Articles and Columns »

Weekly CEO Buy Highlight: Winmark Corp, Alexza Pharmaceuticals Inc, Ladenburg Thalmann Financial Services In, C&D Technologies Inc.

October 11, 2009 | About:
guruyt

guruyt

4 followers
Last week's top stocks that were bought by their CEOs were Winmark Corp, Alexza Pharmaceuticals Inc, Ladenburg Thalmann Financial Services In, andC&D Technologies Inc. According to GuruFocus Insider Data, these are the largest CEO buys during the past week.


Winmark Corp. (WINA): Chairman & CEO, 10% Owner John L Morgan Bought 13,131 Shares


Chairman & CEO, 10% Owner of Winmark Corp. (WINA) John L Morgan bought 13,131 shares on 10/07/2009 at an average price of $21.5. Winmark Corporation is a franchise company that franchises seven retail concepts which buy sell trade and consign merchandise. Each concept operates in a different industry and provides the consumer with 'ultra-high value' retailing. The company began franchising the Play It Again Sports store concept and through a series of acquisitions has expanded its operations. Winmark Corp. has a market cap of $109.91 million; its shares were traded at around $21.5 with a P/E ratio of 24.13 and P/S ratio of 3.1.


Winmark Corporation (Nasdaq; WINA) announced today net income for the quarter ended June 27, 2009 of $1,195,300, or $.22 per share diluted, compared to net income of $930,500, or $.17 per share diluted, in 2008.


Buy: Director Dean B Phillips bought 1,000 shares of WINA stock on 08/27/2009 at the average price of $21.1; the price of the stock has increased by 1.9% since. Other insiders in the company have also increased their positions in the company.


Alexza Pharmaceuticals Inc. (ALXA): Pres & CEO Thomas Braxton King Bought 64,655 Shares


Pres & CEO of Alexza Pharmaceuticals Inc. (ALXA) Thomas Braxton King bought 64,655 shares on 10/05/2009 at an average price of $2.3899. Alexza Pharmaceuticals is an emerging pharmaceutical company focused on the development and commercialization of novel proprietary products for the treatment of acute and intermittent conditions. The Company has a market cap of $73.82 million; its shares were traded at around $2.3899 with and P/S ratio of 151.89.


Alexza recently reported its second quarter results. The company announced that it had a net loss of $17 million, compared to $20 million a year ago. "During the second quarter, we continued the wind-up of our clinical program for AZ-004 (Staccato((R)) loxapine), initiating the four remaining NDA-supporting studies and completing two of them. We project to complete all of our NDA-related clinical work by the end of the third quarter," said Thomas B. King, Alexza President and CEO. "In June, we announced the purchase of Symphony Allegro, allowing us to reacquire full ownership of AZ-004, AZ-104 and AZ-002. This is an important step in the commercialization strategy, as we remain on target for our AZ-004 NDA submission in the first quarter of 2010."


Buy: Pres & CEO [url= http://www.gurufocus.com/InsiderBuy.php?insider=KING+THOMAS+BRAXTON]Thomas Braxton King [/url] bought 64,655 shares of ALXA stock on 10/05/2009 at the average price of $2.32; the price of the stock has increased by 3.01% since.


Ladenburg Thalmann Financial Services In (LTS): President and CEO Richard Lampen Bought 10,000 Shares


President and CEO of Ladenburg Thalmann Financial Services In (LTS) Richard Lampen bought 10,000 shares on 10/05/2009 at an average price of $0.7. Ladenburg Thalmann Financial Services is a holding company engaged in the retail and institutional securities brokerage business and through its subsidiary GBI Capital Partners Inc.(formerly Gaines Berland Inc. provide investment banking and research services. Ladenburg Thalmann Financial Services In has a market cap of $113.95 million; its shares were traded at around $0.7 with and P/S ratio of 0.94.


Buy: President and CEO Richard Lampen bought 10,000 shares of LTS stock on 10/05/2009 at the average price of $0.68; the price of the stock has increased by 2.94% since. Buy: Vice President and CFO Brett Kaufman bought 5,000 shares of LTS stock on 06/26/2009 at the average price of $0.53; the price of the stock has increased by 32.08% since.


C&D Technologies Inc. (CHP): President & CEO Jeffrey A Graves Bought 3,000 Shares


President & CEO of C&D Technologies Inc. (CHP) Jeffrey A Graves bought 3,000 shares on 10/05/2009 at an average price of $2. C&D Technologies Inc. is a leading North American producer of integrated reserve power systems for telecommunications electronic information and industrial applications. The company is also a leading producer of embedded high frequency switching power supplies. The power supplies are used in telecommunications equipment advanced office electronic machines such as copiers and motive power systems for electric industrial vehicles. C&d Technologies Inc. has a market cap of $52.87 million; its shares were traded at around $2 with and P/S ratio of 0.14.


C&D recently reported its second quarter 2010 fiscal results.The company announced that its revenus rose 11/9%, driven by an 8% sequential increase in volumes. The company said that it had a net loss of $5.6 million, or 21 cents per share in the quarter, compared to a net loss of 37 cents per share a year ago.


Buy: President & CEO Jeffrey A Graves bought 3,000 shares of CHP stock on 10/05/2009 at the average price of $2; the price of the stock has decreased by 0% since.


For the complete list of stocks that bought by their company CEOs, go to: CEO Buys.


  • CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
  • Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
  • Double Buys:: Companies that both Gurus and Insiders are buying
  • Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.

» Take a Free Trial of Premium Membership


Rating: 4.0/5 (2 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide